Patent 8637083 was granted and assigned to BIND Therapeutics on January, 2014 by the United States Patent and Trademark Office.
The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.